AAMWA has built a national community-health platform that brings preventive health education, screenings and resources directly into the communities it serves. Through Black Men’s Wellness Day, AAMWA engaged more than 100,000 participants across nearly 20 cities and provided more than 10,000 free health screenings through its 2025 national tour, as reported in 2026. Through Uplift Her, AAMWA engaged nearly 10,000 attendees and delivered more than 3,700 individual health screenings, with support from more than 300 volunteers and 250 community partners and organizations. The initiative also provided 15 mammograms and generated 516 follow-up referrals for elevated blood pressure, glucose and cholesterol, demonstrating AAMWA’s ability to connect large-scale community engagement with preventive health services, early detection and follow-up resources.
Purpose – to support Novartis’ community-health efforts by using AAMWA’s trusted community infrastructure to increase awareness, education, outreach, and connection to health resources in communities experiencing disparities.
This campaign matters – Together, Novartis and AAMWA brings trusted health education and resources directly into communities, making it easier for people to understand their risks, get checked, and take action. We are addressing health disparities and creating stronger connections between communities and the care they need.
Program goals:
Educate: Increase community awareness and understanding of breast and prostate cancer.
Prevent & Detect: Promote proactive health behaviors, risk reduction, screening and early detection.
Engage & Navigate: Facilitate meaningful community conversations and provide resources, referrals and participant navigation.
Reach & Measure: Expand culturally relevant outreach and measure program activities and outcomes to inform continuous improvement.
Community Impact – Increase community awareness, education and engagement around breast and prostate cancer while promoting prevention, early detection, proactive care and access to resources. Through culturally relevant outreach, community conversations, screening-focused activations and participant navigation, the program is designed to create measurable impact in the communities served.
Campaign Overview
The program is a community-based breast and prostate cancer initiative designed to support the full care continuum through culturally relevant awareness and education, prevention and risk reduction, screening and early detection, community engagement, and care navigation. Through community activations, trusted partnerships, outreach, educational resources and measurable follow-up, the program seeks to improve access to information and resources while supporting stronger breast and prostate cancer outcomes across priority communities.
The health information contained in this material is based on guidance and research from the American Cancer Society (ACS), Centers for Disease Control and Prevention (CDC), National Cancer Institute (NCI), U.S. Preventive Services Task Force (USPSTF), and other nationally recognized cancer organizations.
This information is intended for educational purposes only and should not replace advice from your healthcare provider. Talk with your physician or healthcare team about the screening schedule that is right for you based on your age, family history, and personal risk factors.
Prostate cancer is the second most common cancer among men in the United States. Novartis estimates that approximately 35,770 men will die from prostate cancer in 2025—nearly 100 men every day.
The burden is not experienced equally. Novartis reports that Black men have the highest prostate cancer death rate of any racial or ethnic group in the United States—more than twice the rate of White men.
Novartis also emphasizes that prostate cancer is a family disease, affecting not only the individual diagnosed but also families and caregivers. Its community work includes education, collaboration and investment intended to help people navigate the prostate cancer journey.
Key Statistics Used
Primary Sources
American Cancer Society
Cancer Facts & Figures for African American/Black People
Centers for Disease Control and Prevention (CDC)
Prostate Cancer
National Cancer Institute
Provides evidence-based information on:
U.S. Preventive Services Task Force (USPSTF)
Current recommendation:
Breast cancer is the most commonly diagnosed cancer in the United States. Approximately 1 in 8 women (13%) will develop breast cancer during their lifetime, with an estimated 316,950 women diagnosed in 2025. Men can also develop breast cancer, with approximately 2,800 new cases of invasive breast cancer expected in 2025.
Novartis also highlights that more than 90% of breast cancer diagnoses are early-stage, but recurrence remains a concern, particularly during the first several years following diagnosis.
For Black women, the stakes are particularly significant: Novartis reports that Black women are 41% more likely to die from breast cancer than White women in the United States. The company says its community-health efforts focus on increasing screening, improving access to resources and helping Black patients and providers navigate the entire breast cancer care journey.
Key Statistics Used
Primary Sources
American Cancer Society
Reports that:
Centers for Disease Control and Prevention
Provides information on:
National Cancer Institute
Provides evidence regarding:
U.S. Preventive Services Task Force
Current recommendation:
.
